Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma

Clinical Endocrinology

Volumn 78, Issue 6, 2013, Pages 898-906

  Jafri, Mariam ^a,b   Whitworth, James ^a,c   Rattenberry, Eleanor ^a,c   Vialard, Lindsey ^c   Kilby, Gail ^a,c   Kumar, Ajith V ^d   Izatt, Louise ^e   Lalloo, Fiona ^f   Brennan, Paul ^g   Cook, Jackie ^h   Morrison, Patrick J ⁱ   Canham, Natalie ^j   Armstrong, Ruth ^k   Brewer, Carole ^l   Tomkins, Susan ^m   Donaldson, Alan ^m   Barwell, Julian ⁿ   Cole, Trevor R ^c   Atkinson, A Brew ^o   Aylwin, Simon ^p   Ball, Steve G ^q   Srirangalingam, Umasuthan ^r   Chew, Shern L ^r   Evans, Dafydd Gareth R ^f   Hodgson, Shirley V ^s   Irving, Richard ^b   Woodward, Emma ^a,c   MacDonald, Fiona ^c   Maher, Eamonn R ^a,c   more..

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^g NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

ⁱ QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^j NORTHWICK PARK HOSPITAL   (United Kingdom)

^k ADDENBROOKE S HOSPITAL   (United Kingdom)

^l Royal Devon and Exeter   (United Kingdom)

^m ST MICHAEL'S HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY OF LEICESTER   (United Kingdom)

^o ROYAL VICTORIA HOSPITAL   (United Kingdom)

^p KING'S COLLEGE LONDON   (United Kingdom)

^q UNIVERSITY OF LEEDS   (United Kingdom)

^r ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^s ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE D; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEAD AND NECK PARAGANGLIOMA; HEAD AND NECK TUMOR; HETEROZYGOTE; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATION RATE; MUTATIONAL ANALYSIS; NON SYNDROMIC PHEOCHROMOCYTOMA; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PARAGANGLIOMA; PENETRANCE; PHEOCHROMOCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SPLICING DEFECT;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84876557637     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12074     Document Type: Article

References (38)

1. Burnichon, N., Rohmer, V., Amar, L., et al,. (2009) The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. The Journal of Clinical Endocrinology and Metabolism, 94, 2817-2827.
2. Neumann, H.P., Erlic, Z., Boedeker, C.C., et al,. (2009) Clinical predictors for germline mutations in head & neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Research, 69, 3650-3656.
3. Jafri, M., &, Maher, E.R., (2012) GENETICS IN ENDOCRINOLOGY: the genetics of phaeochromocytoma: using clinical features to guide genetic testing. European Journal of Endocrinology, 166, 151-158.
4. Erlic, Z., Rybicki, L., Peczkowska, M., et al,. (2009) Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 15, 6378-6385.
5. Astuti, D., Douglas, F., Lennard, T.W., et al,. (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet, 357, 1181-1182.
6. Astuti, D., Latif, F., Dallol, A., et al,. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. The American Journal of Human Genetics, 69, 49-54.
7. Neumann, H.P.H., Bausch, B., McWhinney, S.R., et al,. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine, 346, 1459-1466.
8. Brauch, H., Kishida, T., Glavac, D., et al,. (1995) Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Human Genetics, 95, 551-556.
9. Hensen, E.F., van Duinen, N., Jansen, J.C., et al,. (2012) High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Clinical Genetics, 81, 284-288.
10. Ricketts, C.J., Forman, J.R., Rattenberry, E., et al,. (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Human Mutation, 31, 41-51.
11. Bayley, J.-P., Devilee, P., &, Taschner, P., (2005) The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Medical Genetics, 6, 39.
12. Burnichon, N., Vescovo, L., Amar, L., et al,. (2011) Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Human Molecular Genetics, 20, 3974-3985.
13. Henderson, A., Douglas, F., Perros, P., &, Maher, E.R., SDHB associated renal oncocytoma suggests broadening of the renal phenotype in heriditary paragangliomas Familial Cancer, 8(5), 257-260.
14. Ladroue, C., Carcenac, R., Leporrier, M., et al,. (2008) PHD2 mutation and congenital erythrocytosis with paraganglioma. New England Journal of Medicine, 359, 2685-2692.
15. Yeh, I.T., Lenci, R.E., Qin, Y., et al,. (2008) A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Human Genetics, 124, 279-285.
16. Abermil, N., Guillaud-Bataille, M., Burnichon, N., et al,. (2012) TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma. Journal of Clinical Endocrinology & Metabolism, 97, E805-E809.
17. Bayley, J.P., Kunst, H.P., Cascon, A., et al,. (2010) SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. The Lancet Oncology, 11, 366-372.
18. Burnichon, N., Briere, J.J., Libe, R., et al,. (2010) SDHA is a tumor suppressor gene causing paraganglioma. Human Molecular Genetics, 19, 3011-3020.
19. Burnichon, N., Cascõn, A., Schiavi, F., et al,. (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clinical Cancer Research, 18, 2828-2837.
20. Kunst, H.P., Rutten, M.H., de Monnink, J.P., et al,. (2011) SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 17, 247-254.
21. Amar, L., Bertherat, J., Baudin, E., et al,. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology, 23, 8812-8818.
22. Boedeker, C.C., Erlic, Z., Richard, S., et al,. (2009) Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. The Journal of Clinical Endocrinology and Metabolism, 94, 1938-1944.
23. Cascõn, A., Pita, G., Burnichon, N., et al,. (2009) Genetics of pheochromocytoma and paraganglioma in spanish patients. Journal of Clinical Endocrinology & Metabolism, 94, 1701-1705.
24. Neumann, H.P., Pawlu, C., Peczkowska, M., et al,. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB & SDHD gene mutations. JAMA, 292, 943-951.
25. Pacak, K., Eisenhofer, G., Ahlman, H., et al,. (2007) Pheochromocytoma: recommendations for clinical practice from the Symposium, First International. Nature Clinical Practice. Endocrinology and Metabolism, 3, 92-102.
26. Qin, Y., Yao, L., King, E.E., et al,. (2010) Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nature Genetics, 42, 229-233.
27. Niemann MU, S., (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genetics, [Support, Research & Non-Gov't, U.S.] 26, 268-270.
28. Boedeker, C.C., Neumann, H.P.H., Maier, W., et al,. (2007) Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngology and Head and Neck Surgery, 137, 126-129.
29. Ricketts, C., Woodward, E.R., Killick, P., et al,. (2008) Germline, SDHB mutations & familial renal cell carcinoma. Journal of the National Cancer Institute, 100, 1260-1262.
30. Xekouki, P., &, Stratakis C.A., (2012) Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects? Endocrine-Related Cancer, 19, C33-40.
31. McWhinney, S.R., Pasini, B., &, Stratakis, C.A., (2007) Familial gastrointestinal stromal tumors and germ-line mutations. New England Journal of Medicine, 357, 1054-1056.
32. Ni, Y., He, X., Chen, J., et al,. (2012) Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Human Molecular Genetics, 21, 300-310.
33. Korpershoek, E., Favier, J., Gaal, J., et al,. (2011) SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. The Journal of Clinical Endocrinology and Metabolism, 96, E1472-E1476.
34. van Nederveen, F.H., Gaal, J., Favier, J., et al,. (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. The Lancet Oncology, 10, 764-771.
35. Neumann, H.P., Sullivan, M., Winter, A., et al,. (2011) Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. The Journal of Clinical Endocrinology and Metabolism, 96, E1279-E1282.
36. Benn, D.E., Gimenez-Roqueplo, A.P., Reilly, J.R., et al,. (2006) Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. The Journal of Clinical Endocrinology and Metabolism, 91, 827-836.
37. Hes, F.J., Weiss, M.M., Woortman, S.A., et al,. (2010) Low penetrance of a SDHB mutation in a large Dutch paraganglioma family. BMC Medical Genetics, 11, 92.
38. Schiavi, F., Milne, R.L., Anda, E., et al,. (2010) Are we overestimating the penetrance of mutations in SDHB? Human Mutation, 31, 761-762.